REQUEST A DEMO
Total
USD $0.00
Search more companies

Specjalmed II Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Pharmacies and Drug Stores | Department Stores | Ambulatory Health Care Services | Offices of Physicians | Offices of All Other Miscellaneous Health Practitioners
Full name: Specjalmed II Sp. z o.o. Profile Updated: August 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Specjalmed II Sp. z o.o. is based in Poland, with the head office in Dobczyce. It operates in the General Medical and Surgical Hospitals sector. It was first established on March 17, 2023. In its most recent financial highlights, the company reported a net sales revenue increase of 29.11% in 2023. Its total assets grew by 20.91% over the same period. In, 2023, the company’s net profit margin increased by 0.23%.

Headquarters
Ul. Zarabie 35C
Dobczyce; Malopolskie; Postal Code: 32-410

Contact Details: Purchase the Specjalmed II Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Specjalmed II Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Specjalmed II Sp. z o.o. report to view the information.
Incorporation Date:
March 17, 2023
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Specjalmed II Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
29.11%
Total operating revenue
28.69%
Operating profit (EBIT)
25.46%
EBITDA
42.4%
Net Profit (Loss) for the Period
31.52%
Total assets
20.91%
Total equity
53.96%
Operating Profit Margin (ROS)
-0.41%
Net Profit Margin
0.23%
Return on Equity (ROE)
-6.18%
Debt to Equity Ratio
-14.27%
Quick Ratio
0.65%
Cash Ratio
0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?